649 related articles for article (PubMed ID: 16445554)
41. Association of HCV and Treponema pallidum infection in HIV infected northeastern Thai male blood donors.
Barusrux S; Urwijitaroon Y; Puapairoj C; Romphruk A; Sriwanitchrak P
J Med Assoc Thai; 1997 Sep; 80 Suppl 1():S106-11. PubMed ID: 9347656
[TBL] [Abstract][Full Text] [Related]
42. HIV prevalence and factors associated with HIV infection among male injection drug users under 30: a cross-sectional study in Long An, Vietnam.
Tran TM; Nguyen HT; Yatsuya H; Hamajima N; Nishimura A; Ito K
BMC Public Health; 2006 Oct; 6():248. PubMed ID: 17029648
[TBL] [Abstract][Full Text] [Related]
43. The relative risk of HIV among IDUs not in treatment in Malaysia.
Vicknasingam B; Narayanan S; Navaratnam V
AIDS Care; 2009 Aug; 21(8):984-91. PubMed ID: 20024754
[TBL] [Abstract][Full Text] [Related]
44. Trends in HCV prevalence, risk factors and distribution of viral genotypes in injecting drug users: findings from two cross-sectional studies.
Oliveira ML; Yoshida CF; Telles PR; Hacker MA; Oliveira SA; Miguel JC; do O KM; Bastos FI
Epidemiol Infect; 2009 Jul; 137(7):970-9. PubMed ID: 19144250
[TBL] [Abstract][Full Text] [Related]
45. Prevalence, incidence and risk factors for hepatitis C in homosexual men: data from two cohorts of HIV-negative and HIV-positive men in Sydney, Australia.
Jin F; Prestage GP; Matthews G; Zablotska I; Rawstorne P; Kippax SC; Kaldor JM; Grulich AE
Sex Transm Infect; 2010 Feb; 86(1):25-8. PubMed ID: 19841001
[TBL] [Abstract][Full Text] [Related]
46. Epidemic of HIV coupled with hepatitis C virus among injecting drug users of Himalayan West Bengal, Eastern India, Bordering Nepal, Bhutan, and Bangladesh.
Sarkar K; Bal B; Mukherjee R; Chakraborty S; Niyogi SK; Saha MK; Bhattacharya SK
Subst Use Misuse; 2006; 41(3):341-52. PubMed ID: 16467010
[TBL] [Abstract][Full Text] [Related]
47. HIV infection among injecting drug users in north-east Malaysia, 1992.
Singh S; Crofts N
AIDS Care; 1993; 5(3):273-81. PubMed ID: 8218462
[TBL] [Abstract][Full Text] [Related]
48. The risk of HIV and HCV infections among injection drug users in northeast India.
Mahanta J; Borkakoty B; Das HK; Chelleng PK
AIDS Care; 2009 Nov; 21(11):1420-4. PubMed ID: 20024719
[TBL] [Abstract][Full Text] [Related]
49. Hepatitis C virus among genitourinary clinic attenders in Scotland: unlinked anonymous testing.
Goldberg D; Cameron S; Sharp G; Burns S; Scott G; Molyneaux P; Scoular A; Downie A; Taylor A
Int J STD AIDS; 2001 Jan; 12(1):17-21. PubMed ID: 11177477
[TBL] [Abstract][Full Text] [Related]
50. Epidemiological and genetic analyses of Hepatitis C virus transmission among young/short- and long-term injecting drug users from Rio de Janeiro, Brazil.
Oliveira Mde L; Bastos FI; Telles PR; Hacker Mde A; Oliveira SA; Miguel JC; Yoshida CF
J Clin Virol; 2009 Mar; 44(3):200-6. PubMed ID: 19195927
[TBL] [Abstract][Full Text] [Related]
51. Human immunodeficiency virus type 1 and hepatitis C virus co-infection and viral subtypes at an HIV testing center in Brazil.
Pereira GA; Stefani MM; Martelli CM; Turchi MD; Siqueira EM; Carneiro MA; Martins RM
J Med Virol; 2006 Jun; 78(6):719-23. PubMed ID: 16628586
[TBL] [Abstract][Full Text] [Related]
52. Hepatitis C prevalence and needle/syringe sharing behaviours in recent onset injecting drug users.
Robinson GM; Reynolds JN; Robinson BJ
N Z Med J; 1995 Mar; 108(996):103-5. PubMed ID: 7715873
[TBL] [Abstract][Full Text] [Related]
53. [Prevalence of hepatitis B, hepatitis C and HIV among injecting drug users treated outpatiently and in therapeutic community in Brod-Posavina County, Croatia].
Kolovrat A; Jurisić I; Marić Z; Cvitković A
Acta Med Croatica; 2010 Oct; 64(4):287-96. PubMed ID: 21688612
[TBL] [Abstract][Full Text] [Related]
54. "I inject less as I have easier access to pipes": injecting, and sharing of crack-smoking materials, decline as safer crack-smoking resources are distributed.
Leonard L; DeRubeis E; Pelude L; Medd E; Birkett N; Seto J
Int J Drug Policy; 2008 Jun; 19(3):255-64. PubMed ID: 18502378
[TBL] [Abstract][Full Text] [Related]
55. [Risk factors for hepatitis C among injecting drug users in Oslo].
Dalgard O; Egeland A; Ervik R; Vilimas K; Skaug K; Steen TW
Tidsskr Nor Laegeforen; 2009 Jan; 129(2):101-4. PubMed ID: 19151801
[TBL] [Abstract][Full Text] [Related]
56. [Risk behaviors of intravenous drug users: are females taking more risks of HIV and HCV transmission?].
Vidal-Trécan G; Coste J; Coeuret M; Delamare N; Varescon-Pousson I; Boissonnas A
Rev Epidemiol Sante Publique; 1998 Jun; 46(3):193-204. PubMed ID: 9690286
[TBL] [Abstract][Full Text] [Related]
57. Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia.
Maher L; Jalaludin B; Chant KG; Jayasuriya R; Sladden T; Kaldor JM; Sargent PL
Addiction; 2006 Oct; 101(10):1499-508. PubMed ID: 16968352
[TBL] [Abstract][Full Text] [Related]
58. [Prevalence of human immunodeficiency virus infection and behaviors associated with its transmission among parenteral drug users selected on the street].
Rodés A; Vall M; Casabona J; Nuez M; Rabella N; Mitrani L
Med Clin (Barc); 1998 Oct; 111(10):372-7. PubMed ID: 9833239
[TBL] [Abstract][Full Text] [Related]
59. Hepatitis C and its risk management among drug injectors in London: renewing harm reduction in the context of uncertainty.
Rhodes T; Davis M; Judd A
Addiction; 2004 May; 99(5):621-33. PubMed ID: 15078237
[TBL] [Abstract][Full Text] [Related]
60. Sexual transmission risk among noninjecting heroin users infected with human immunodeficiency virus or hepatitis C virus.
Neaigus A; Miller M; Friedman SR; Des Jarlais DC
J Infect Dis; 2001 Aug; 184(3):359-63. PubMed ID: 11443564
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
